^{<ins id="ko8hs"></ins>}<dl id="ko8hs"><strike id="ko8hs"><nobr id="ko8hs"></nobr></strike></dl>

熱門關(guān)鍵詞：進(jìn)口ELISA試劑盒，人ELISA試劑盒，大鼠elisa試劑盒價(jià)格，小鼠elisa試劑盒價(jià)格，豬elisa試劑盒，雞elisa試劑盒，兔elisa試劑盒，魚elsa試劑盒，其他種屬elisa試劑盒，豚鼠elisa試劑盒，倉鼠elisa試劑盒，裸鼠ELISA試劑盒，進(jìn)口試劑，血清，動(dòng)物血清，人血清，胎牛血清，氨基酸試劑，培養(yǎng)基，顯色培養(yǎng)基，大腸桿菌O157培養(yǎng)基，細(xì)菌總數(shù)培養(yǎng)基，金黃色葡萄球菌檢驗(yàn)培養(yǎng)基，沙門氏菌/賀氏菌檢驗(yàn)培養(yǎng)基，弧菌檢驗(yàn)培養(yǎng)基，其他培養(yǎng)基，酵母霉菌青霉曲霉培養(yǎng)基，李斯特氏菌檢驗(yàn)培養(yǎng)基，抗體，二抗，一抗，生物試劑，酶生物試劑，蛋白質(zhì)試劑，抗生素試劑，植物激素及核酸試劑，碳水化合物試劑，色素試劑，維生素試劑，表面活性劑，緩沖試劑，其他生化試劑，標(biāo)準(zhǔn)品對照品類，對照品，對照藥材，標(biāo)準(zhǔn)品，標(biāo)準(zhǔn)試劑，Spectrum試劑，美國藥典級試劑等

產(chǎn)品中心PRODUCTS

查看全部

相關(guān)文章

RELEVANT ARTICLES

產(chǎn)品中心您現(xiàn)在的位置：首頁 > 產(chǎn)品展示 > > 細(xì)胞株 > Zalcitabine Related Compound A ，7481-88-1

Zalcitabine Related Compound A ，7481-88-1

簡要描述：

Zalcitabine Related Compound A ，7481-88-1

來源：USP

所有解釋權(quán)歸上海義森生物有限公司。

更新時(shí)間：2024-09-10

上海義森生物有限公司：Zalcitabine Related Compound A ，7481-88-1

Zalcitabine Related Compound A （50 mg）（2',3'-Didehydro-2',3'-dideoxycytidine）

Catalog #	1724317
Current Lot	F0B234
Previous Lot	N/A
MSDS	View
USP Certificate
CAS#	7481-88-1
In Stock	Yes

上海義森生物有限公司：Zalcitabine，7481-89-2

USP里程碑

Milestone of 3,000 USP Reference Standards

Public Health Supported by Breadth of Quality Standards

Rockville, Md., March 5, 2013 — In a milestone representing a significant contribution to public health, the U.S. Pharmacopeial Convention （USP） announces that it has grown its portfolio of reference standards to now include 3,000 items. USP Reference Standards are highly characterized samples of active pharmaceutical ingredients and impurities, food chemicals, and dietary supplements and their ingredients. Regulators and manufacturers use USP Reference Standards to assess products’ conformity to standards of identity, quality, purity and strength. USP Reference Standards are specified in the monographs of the U.S. Pharmacopeia and National Formulary （USP–NF）, USP’s flagship compendia of quality standards; the Food Chemicals Codex （for food ingredients）, the Dietary Supplements Compendium, and the new Medicines Compendium. Drugs sold or manufactured in the United States are required by law to comply with standards published in the USP–NF, and these standards are enforceable by the Food and Drug Administration.

“Attaining 3,000 USP Reference Standards is important for USP, of course, but also for all stakeholders interested in advancing public health,” said Roger L. Williams, M.D., chief executive officer at USP. “USP relies on our volunteer experts who, with staff, set the standards, and on the manufacturers who donate the monographs and materials from which many of our standards are derived. Both are equally crucial in the standards-setting process, and I want to take this opportunity to thank all who understand the importance of public standards.”

Dr. Williams also noted USP’s focused effort over the last decade to strengthen USP’s public standards. This effort is ongoing, and is summarized in USP’s policy statements and in a stimuli article.

USP distributes thousands of units of its Reference Standards every year to customers in more than 140 countries around the world. The breadth and depth of the USP catalog means that regulators and manufacturers have the fullest available complement of publicly available standards to help ensure the quality of medicines, foods and dietary supplements throughout the supply chain, from manufacturers to practitioners, patients and consumers.